Lipocine Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Lipocine Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2012 to Q2 2024.
  • Lipocine Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $481.000.
  • Lipocine Inc. annual Income Tax Expense (Benefit) for 2023 was $755.000, a 10.9% increase from 2022.
  • Lipocine Inc. annual Income Tax Expense (Benefit) for 2022 was $681.000, a 241% increase from 2021.
  • Lipocine Inc. annual Income Tax Expense (Benefit) for 2021 was $200.000, unchanged from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $481 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $200 $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $200 $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $200 $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $200 $200 $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $200 $0 $0 Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 $200 $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $200 $0 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $200 $200 $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $200 $0 $0 Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $200 $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $200 $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $200 $200 -$500 -71.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $700 $0 $0 Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 $700 $0 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $700 $0 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $700 $700 $0 0% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $700 $0 -$52 -100% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 $752 $0 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $752 $0 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $752 $700 $0 0% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 $752 $52.00 +$52.00 Oct 1, 2016 Dec 31, 2016 10-K 2019-03-06
Q3 2016 $700 $0 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $700 $0 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $700 $700 +$500 +250% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $200 $0 -$200 -100% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 $400 $0 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $400 $0 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $400 $200 +$200 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $200 $200 +$200 Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 $0 $0 +$55.3K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$55.3K $0 -$182 -100% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$55.2K $0 -$112 -100% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$55K $0 Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 -$55.3K -$55.5K -32464% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $182 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $112 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q3 2012 $171 Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.